News

In 2017, NADFC starts to conduct the supervision of the implementation of pharmacovigilance for HIV/AIDS, Tuberculosis, Malaria (ATM) drug programs. The supervision is conducted in order to implement Ministerial Decree of Ministry of Health Republic of Indonesia Number HK.02.02/ Menkes/164/2015 Date of April 30, 2015 on the Tryout of Pharmacovigilance for HIV/AIDS, Tuberculosis, Malaria (ATM) drugs at Healthcare service facilities. Those Healthcare service facilities conducting the tryouts according to the Decree are as follow:

AIDS PROGRAM

A.          DKI JAKARTA

·               South Jakarta

1. Fatmawati Central General Hospital

2. Tebet Community Health Center

3.  Cilandak Community Health Center

4.  Pasar Minggu Community Health Center

·               Central Jakarta

1.  Tarakan Regional General Hospital

2.  Gambir Community Health Center

3.   Senen Community Health Center

4.  Tanah Abang Community Health Center

·               North Jakarta

1.  Infectious Disease Hospital of Sulianti Saroso

2.  Tanjung Priok Community Health Center

3.   Penjaringan Community Health Center

4.   Koja Community Health Center

B.           PAPUA

·               Kota Jayapura

1.   Dok Dua Hospital

2.   Hamadi Community Health Center

 

 

TUBERCULOSIS PROGRAM

A.     EAST JAVA

·   Surabaya City (Central General Hospital of Dr. Soetomo)

·    Lumajang Regency (Regional General Hospital of Hartoyo)

·   Tuban Regency (Community Health Center of Palang)

·     Madiun City (Med-clinic for Lung Disease Treatment)

B.     WEST JAVA

·               Bandung City

1.  Central General Hospital of Dr. Hasan Sadikin

2.    Pulmonary Central Clinic of Bandung

C.           WEST NUSA TENGGARA

·               East Lombok Regency

1.    Sambelia Community Health Center

2.     Labuhan Lombok Community Health Center

 

MALARIA PROGRAM

A.          PAPUA

·               Jayapura City

1.  Dok Dua Hospital

2.   Hamadi Community Health Center

B.           WEST NUSA TENGGARA

·               East Lombok Regency (Belating Community Health Center)

C.           MALUKU PROVINCE

·               Ambon City

1.  CH. M. Tiahahu Community Health Center

2.   Salobar Community Health Center

3.   Passo Community Health Center

 

In May 2017 the supervision of Pharmacovigilance implementation for HIV/AIDS and Malaria drug programs at Healthcare Service Facilities was conducted in Jayapura.

Afterward, In August 2017, NADFC together with Sub-directorate AIDS and Sexual Transmitted Disease Control Ministry of Health Republic of Indonesia, Health Department of Jakarta Province, Public Health Service of North Jakarta, and Provincial Office of NADFC in Jakarta conducted a supervision of pharmacovigilance implementation for HIV/AIDS drug program in Jakarta Province. Some healthcare service facilities were supervised. Those were Tarakan Regional General Hospital, Sulianti Saroso Infectious Disease Hospital, Tanah Abang Community Health Center, Koja Community Health Center, and Tanjung priok Community Health Center.

Since the dissemination and training of the guidelines of the implementation of drug pharmacovigilance for ATM (AIDS Tuberculosis, Malaria) program at the end of 2014, until now ESO reports of drugs for HIV/AIDS received by NADFC are only a few. The supervision result of drug pharmacovigilance implementation for HIV/AIDS program indicates that there are many obstacles faced by the officers of Health Service Facilities concerning the implementation of pharmacovigilance.

 

To follow up the supervision result mentioned above, on October 6, 2017, NADCF, Sub Directorate of AIDS and Sexual Transmitted Diseases Control-Ministry of Health Republic of Indonesia, Health Department of Jakarta Province, Public Health Service of North Jakarta, Public Health Service of Central Jakarta, and representatives of Health Service Facilities which were being supervised conducted an evaluation meeting of drug pharmacovigilance implementation for HIV/AIDS program. They discussed the follow-up plans would be taken to overcome the obstacles. The follow-up plans that will be taken are among others: there will be a follow-up meeting to discuss the mechanism of a simpler ESO reporting, continuous pharmacovigilance training for health personnel, periodical coordination and communication meetings, and sustainable supervision of pharmacovigilance implementation.

NADFC understands that drug pharmacovigilance implementation for ATM program in Indonesia is easy and it needs supports from various related parties. Through sustainable supervisions of drugs for ATM program, NADFC along with Health Ministry will accompany the health service facilities in implementing drug pharmacovigilance for ATM program for the safety use of ATM drugs and for patient safety.

Poll
How do you think the content and appearance of this website?




logo dsras Email Rapid Alert System

Selamat email anda telah berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia.

 

logo dsras Email Rapid Alert System

Anda ingin berhenti berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia?